Cancer Research AMC Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gildea, J. J.
Right arrow Articles by Theodorescu, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gildea, J. J.
Right arrow Articles by Theodorescu, D.
[Cancer Research 62, 982-985, February 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

The Role of Ral A in Epidermal Growth Factor Receptor-regulated Cell Motility1

John J. Gildea, Michael A. Harding, M. Jabed Seraj, Kay M. Gulding and Dan Theodorescu2

Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908

Tumor cell motility is one of the rate-limiting steps of invasion, which defines progression toward a more malignant phenotype. Elevated expression of epidermal growth factor (EGF) receptor in many cancers is associated with progression of superficial to invasive forms of the disease and is sometimes found in tumors that also have activating Ras mutations, suggesting that both events contribute to tumor invasion. Here we show that EGF stimulates motility in human tumor cell lines, which harbor activating Ha-RasV12 via a novel signal transduction pathway mediated by the small GTP-binding proteins RalA and RhoA but independent of Rac1 and Cdc42. On EGF stimulation, RalA localizes to the cell membrane. In addition, activation of RalA and expression of Rho were increased by EGF stimulation in both the nonmetastatic and metastatic variants of the same cell line. However, elevated levels of constitutively activated RalA were only found in the metastatic variant. This is the first demonstration of an essential role for Ral in EGF-mediated cell motility and its potential contribution to tumor metastasis in human cancer.




This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
T. T. Li, M. Alemayehu, A. I. Aziziyeh, C. Pape, M. Pampillo, L.-M. Postovit, G. B. Mills, A. V. Babwah, and M. Bhattacharya
{beta}-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells
Mol. Cancer Res., July 1, 2009; 7(7): 1064 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. S. Spiczka and C. Yeaman
Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration
J. Cell Sci., September 1, 2008; 121(17): 2880 - 2891.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. J. J. de Gorter, R. M. Reijmers, E. A. Beuling, H. P. H. Naber, A. Kuil, M. J. Kersten, S. T. Pals, and M. Spaargaren
The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells
Blood, April 1, 2008; 111(7): 3364 - 3372.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z Wu, K. McRoberts, and D Theodorescu
The role of PTEN in prostate cancer cell tropism to the bone micro-environment
Carcinogenesis, July 1, 2007; 28(7): 1393 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. C. Smith, G. Oxford, A. S. Baras, C. Owens, D. Havaleshko, D. L. Brautigan, M. K. Safo, and D. Theodorescu
Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3803 - 3813.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Takaya, T. Kamio, M. Masuda, N. Mochizuki, H. Sawa, M. Sato, K. Nagashima, A. Mizutani, A. Matsuno, E. Kiyokawa, et al.
R-Ras Regulates Exocytosis by Rgl2/Rlf-mediated Activation of RalA on Endosomes
Mol. Biol. Cell, May 1, 2007; 18(5): 1850 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. Blanke and H. Jackle
Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42
FASEB J, April 1, 2006; 20(6): 683 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Liu, D. C. Radisky, C. M. Nelson, H. Zhang, J. E. Fata, R. A. Roth, and M. J. Bissell
Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.
PNAS, March 14, 2006; 103(11): 4134 - 4139.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. C. Smith, G. Oxford, Z. Wu, M. D. Nitz, M. Conaway, H. F. Frierson, G. Hampton, and D. Theodorescu
The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human Cancer
Cancer Res., February 15, 2006; 66(4): 1917 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Rosse, A. Hatzoglou, M.-C. Parrini, M. A. White, P. Chavrier, and J. Camonis
RalB Mobilizes the Exocyst To Drive Cell Migration
Mol. Cell. Biol., January 15, 2006; 26(2): 727 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Oxford, C. R. Owens, B. J. Titus, T. L. Foreman, M. C. Herlevsen, S. C. Smith, and D. Theodorescu
RalA and RalB: Antagonistic Relatives in Cancer Cell Migration
Cancer Res., August 15, 2005; 65(16): 7111 - 7120.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. S. Sidhu, R. R. Clough, and R. P. Bhullar
Regulation of Phospholipase C-{delta}1 through Direct Interactions with the Small GTPase Ral and Calmodulin
J. Biol. Chem., June 10, 2005; 280(23): 21933 - 21941.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-C. Wu, T.-Y. Chen, C.-T. R. Yu, S.-J. Tsai, J.-M. Hsu, M.-J. Tang, C.-K. Chou, W.-J. Lin, C.-J. Yuan, and C.-Y. F. Huang
Identification of V23RalA-Ser194 as a Critical Mediator for Aurora-A-induced Cellular Motility and Transformation by Small Pool Expression Screening
J. Biol. Chem., March 11, 2005; 280(10): 9013 - 9022.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Jimenez, I. P. de Castro, M. Benet, J. F. Garcia, G. Inghirami, and A. Pellicer
The Rgr Oncogene Induces Tumorigenesis in Transgenic Mice
Cancer Res., September 1, 2004; 64(17): 6041 - 6049.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al.
Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays
Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. L. Dominguez-Escrig, J. D. Kelly, D. E. Neal, S. M. King, and B. R. Davies
Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer
Clin. Cancer Res., July 15, 2004; 10(14): 4874 - 4884.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Takaya, Y. Ohba, K. Kurokawa, and M. Matsuda
RalA Activation at Nascent Lamellipodia of Epidermal Growth Factor-stimulated Cos7 Cells and Migrating Madin-Darby Canine Kidney Cells
Mol. Biol. Cell, June 1, 2004; 15(6): 2549 - 2557.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Rosse, S. L'Hoste, N. Offner, A. Picard, and J. Camonis
RLIP, an Effector of the Ral GTPases, Is a Platform for Cdk1 to Phosphorylate Epsin during the Switch Off of Endocytosis in Mitosis
J. Biol. Chem., August 15, 2003; 278(33): 30597 - 30604.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Matsuo, H. Sakurai, and I. Saiki
ZD1839, a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Shows Antimetastatic Activity Using a Hepatocellular Carcinoma Model
Mol. Cancer Ther., June 1, 2003; 2(6): 557 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. Mirey, M. Balakireva, S. L'Hoste, C. Rosse, S. Voegeling, and J. Camonis
A Ral Guanine Exchange Factor-Ral Pathway Is Conserved in Drosophila melanogaster and Sheds New Light on the Connectivity of the Ral, Ras, and Rap Pathways
Mol. Cell. Biol., February 1, 2003; 23(3): 1112 - 1124.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. A. Harding, K. C. Arden, J. W. Gildea, J. J. Gildea, E. J. Perlman, C. Viars, and D. Theodorescu
Functional Genomic Comparison of Lineage-related Human Bladder Cancer Cell Lines with Differing Tumorigenic and Metastatic Potentials by Spectral Karyotyping, Comparative Genomic Hybridization, and a Novel Method of Positional Expression Profiling
Cancer Res., December 1, 2002; 62(23): 6981 - 6989.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. J. Gildea, M. J. Seraj, G. Oxford, M. A. Harding, G. M. Hampton, C. A. Moskaluk, H. F. Frierson, M. R. Conaway, and D. Theodorescu
RhoGDI2 Is an Invasion and Metastasis Suppressor Gene in Human Cancer
Cancer Res., November 15, 2002; 62(22): 6418 - 6423.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.